Guglielmo R, Ioime L, Solaroli S, Janiri L
Institute of Psychiatry and Clinical Psychology, Catholic University Medical School of Rome.
Institute of Psychiatry and Clinical Psychology, Catholic University Medical School of Rome - Department of Human Science, Lumsa University of Rome, Italy.
Clin Ter. 2015 Nov-Dec;166(6):262-70. doi: 10.7417/CT.2015.1899.
The main focus of this narrative review is to present and discuss the most relevant clinical data about the pharmacological therapy for alcohol use disorders. By using PubMed we conducted a review of the clinical literature on drugs related to alcohol use disorders. All data are presented following the three phases of treatment: a) from withdrawal to abstinence; b) abstinence and relapse prevention; c) reduction of alcohol consumption. Historical evidence shows that in addition to the drugs already approved for the treatment of alcoholism, there are some off-label medications as effective as the approved ones which deserve therefore further study. The treatment of the alcoholic patient always requires a multidimensional and multidisciplinary approach, directed to the specific needs of each subject in order to achieve a correct care personalization. The study of the cognitive effects of each drug and pharmacogenetics will allow us to increasingly customize therapy for each individual patient.
本叙述性综述的主要重点是呈现和讨论关于酒精使用障碍药物治疗的最相关临床数据。我们通过PubMed对与酒精使用障碍相关药物的临床文献进行了综述。所有数据按照治疗的三个阶段呈现:a)从戒断到戒酒;b)戒酒及预防复发;c)减少酒精摄入量。历史证据表明,除了已获批用于治疗酒精中毒的药物外,还有一些未按药品说明书用药的药物与获批药物一样有效,因此值得进一步研究。酒精成瘾患者的治疗始终需要多维度、多学科的方法,针对每个个体的特定需求,以实现正确的个性化护理。对每种药物的认知效应和药物遗传学的研究将使我们能够越来越多地为每个患者定制治疗方案。